首頁 › 異位性皮膚炎（濕疹） › 德克薩斯州 › Dallas
Dallas, TX 的 異位性皮膚炎（濕疹） 臨床試驗
8 項針對 異位性皮膚炎（濕疹） 的研究正在 Dallas（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
招募中觀察性研究
- Reveal Research Institute - Dallas- Site Number : 8400012, Dallas
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
招募中2 期
- Novartis Investigative Site, Dallas
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
招募中2 期
- Investigational Site, Dallas
A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
招募中2 期
- Enveda Investigative Site, Dallas
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
招募中3 期
- Dermatology Treatment and Research Center /ID# 265812, Dallas
- Modern Research Associates /ID# 263852, Dallas
A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis
招募中2 期
- Dermatology Treatment and Research Center, Dallas
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
招募中觀察性研究
- Galderma Investigational Site 8238, Dallas
Safety and Pharmacokinetics of LPX-TI641 in Atopic Dermatitis and Psoriasis
招募中1 期
- Clinical Investigations of Texas, Dallas
其他城市的 異位性皮膚炎（濕疹） 試驗
- New York City, NY13 項研究
- Los Angeles, CA11 項研究
- Washington, DC11 項研究
- San Antonio, TX10 項研究
- San Diego, CA10 項研究
- Birmingham, AL9 項研究
- Miami, FL9 項研究
- Huntington Beach, CA8 項研究
- Sacramento, CA8 項研究
- Troy, MI8 項研究
- Indianapolis, IN7 項研究
- Pittsburgh, PA7 項研究
Dallas 的其他研究
- 乳癌55 項研究
- 非小細胞肺癌52 項研究
- 轉移性癌症42 項研究
- 心臟衰竭42 項研究
- 癌症（所有類型）37 項研究
- 前列腺癌36 項研究
- 大腸直腸癌33 項研究
- 肥胖症30 項研究
- 卵巢癌28 項研究
- 肺癌27 項研究
- 膀胱癌27 項研究
- 子宮內膜癌24 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。